{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T09:37:13Z","timestamp":1768815433350,"version":"3.49.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"District of Columbia Center for AIDS Research","award":["P30AI117970"],"award-info":[{"award-number":["P30AI117970"]}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R00MH110343"],"award-info":[{"award-number":["R00MH110343"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute on Minority Health and Health Disparities, National Institutes of Health","award":["T37-MD001448"],"award-info":[{"award-number":["T37-MD001448"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Pharmacy-based PrEP service delivery models can help address many of the barriers that inhibit the uptake of PrEP. In an increasing number of states, legislation has been passed, or is under consideration, to allow pharmacists to initiate PrEP without a prescription from a physician or other prescriber. However, there is not yet legislation in Washington, DC to allow pharmacy-based PrEP despite its potential to curb new cases of HIV, which disproportionately affect the Black community in the area. The DC Ends HIV Plan has a goal of less than 130 new cases of HIV per year by 2030, which would require that over 13,000 high-risk residents use PrEP. However, in 2021 only 6,724 Washingtonians were taking PrEP. This study seeks to address the absence of critical formative research into the factors that would influence the implementation of pharmacy-based PrEP in Washington DC using the Implementation Mapping (IM) framework. A needs assessment will be conducted through in-depth interviews (IDIs) with pharmacists (n = 6), PrEP providers (n = 6), current PrEP users (n = 6), DC Department of Health officials (n = 2), DC Board of Pharmacy officials (n = 4) and pharmacy-based PrEP experts (n = 4) to provide input on the operational aspects of pharmacy-based PrEP model as a strategy to increase PrEP uptake. Information gathered through this needs assessment will be used to develop standard operating procedures for the introduction of pilot pharmacy-based PrEP into community-based retail pharmacies.<\/jats:p>","DOI":"10.1371\/journal.pone.0311694","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T17:21:48Z","timestamp":1729099308000},"page":"e0311694","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development of a pharmacy-based HIV PrEP service delivery intervention for Washington, District of Columbia (DC): A study protocol"],"prefix":"10.1371","volume":"19","author":[{"given":"Waimar","family":"Tun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7961-1141","authenticated-orcid":true,"given":"Mamaswatsi","family":"Kopeka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donaldson F.","family":"Conserve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Gomez-Berrospi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Janson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adedotun","family":"Ogunbajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngozi Joy","family":"Idika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenesis","family":"Duran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Lendino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2926-235X","authenticated-orcid":true,"given":"Bezawit","family":"Bekele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya Rezende","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6259-5167","authenticated-orcid":true,"given":"Sumaiya","family":"Nezam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4572-4124","authenticated-orcid":true,"given":"Arona","family":"Dieng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naana","family":"Koranteng-Yorke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"BRIDGE Team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demarc","family":"Hickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"key":"pone.0311694.ref001","unstructured":"District of Columbia Department of Health, HIV\/AIDS, Hepatitis, STI, & TB Administration. Annual Epidemiology & Surveillance Report: Data Through December 2022 [Internet]. 2023. Available from: https:\/\/dchealth.dc.gov\/sites\/default\/files\/dc\/sites\/doh\/publication\/attachments\/2023-Annual-Surveillance-Report-v13.pdf"},{"key":"pone.0311694.ref002","unstructured":"U.S. Census Bureau QuickFacts: District of Columbia [Internet]. [cited 2023 Mar 14]. Available from: https:\/\/www.census.gov\/quickfacts\/DC"},{"key":"pone.0311694.ref003","article-title":"A Review of Health and Socioeconomic Disparities Among Older Black Adults in the District of Columbia","author":"C King","year":"2021","journal-title":"Georgetown University, School of Nursing and Health Studies"},{"issue":"11","key":"pone.0311694.ref004","doi-asserted-by":"crossref","first-page":"e0290631","DOI":"10.1371\/journal.pone.0290631","article-title":"Adapting a community-based intervention to address social determinants of health influencing pre-exposure prophylaxis services for Black adults in Washington, District of Columbia: A study protocol","volume":"18","author":"DF Conserve","year":"2023","journal-title":"PLOS ONE"},{"issue":"12","key":"pone.0311694.ref005","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","article-title":"Effectiveness and safety of oral HIV preexposure prophylaxis for all populations","volume":"30","author":"VA Fonner","year":"2016","journal-title":"AIDS"},{"issue":"12","key":"pone.0311694.ref006","doi-asserted-by":"crossref","first-page":"e790","DOI":"10.1016\/S2352-3018(23)00256-4","article-title":"HIV pre-exposure prophylaxis and its implementation in the PrEP Impact Trial in England: a pragmatic health technology assessment","volume":"10","author":"AK Sullivan","year":"2023","journal-title":"Lancet HIV"},{"issue":"5","key":"pone.0311694.ref007","doi-asserted-by":"crossref","first-page":"e048478","DOI":"10.1136\/bmjopen-2020-048478","article-title":"Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations","volume":"12","author":"E O Murchu","year":"2022","journal-title":"BMJ Open"},{"issue":"1","key":"pone.0311694.ref008","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s10461-016-1466-y","article-title":"The \u201cSafe Sex\u201d Conundrum: Anticipated Stigma From Sexual Partners as a Barrier to PrEP Use Among Substance Using MSM Engaging in Transactional Sex","volume":"21","author":"KB Biello","year":"2017","journal-title":"AIDS Behav"},{"issue":"5","key":"pone.0311694.ref009","first-page":"679","article-title":"Experiences of Pre-Exposure Prophylaxis (PrEP)-Related Stigma among Black MSM PrEP Users in Los Angeles","volume":"97","author":"RA Brooks","year":"2020","journal-title":"J Urban Health Bull N Y Acad Med"},{"issue":"6","key":"pone.0311694.ref010","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1177\/1557988318797437","article-title":"Stigma and Shame Experiences by MSM Who Take PrEP for HIV Prevention: A Qualitative Study","volume":"12","author":"A Dubov","year":"2018","journal-title":"Am J Mens Health"},{"key":"pone.0311694.ref011","unstructured":"[Personal communication; Camilla Stanley; PrEP Coordinator, DC HIV\/AIDS, Hepatitis, STD and TB Administration]. 2023."},{"key":"pone.0311694.ref012","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fpubh.2019.00158","article-title":"Implementation Mapping: Using Intervention Mapping to Develop Implementation Strategies","volume":"7","author":"ME Fernandez","year":"2019","journal-title":"Front Public Health"},{"key":"pone.0311694.ref013","unstructured":"The Consolidated Framework for Implementation Research\u2013Technical Assistance for users of the CFIR framework [Internet]. [cited 2022 Mar 23]. Available from: https:\/\/cfirguide.org\/"},{"issue":"12","key":"pone.0311694.ref014","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1007\/s10461-021-03229-5","article-title":"Acceptability and Feasibility of Pharmacy-Based Delivery of Pre-Exposure Prophylaxis in Kenya: A Qualitative Study of Client and Provider Perspectives","volume":"25","author":"SD Roche","year":"2021","journal-title":"AIDS Behav"},{"issue":"2","key":"pone.0311694.ref015","doi-asserted-by":"crossref","first-page":"e054121","DOI":"10.1136\/bmjopen-2021-054121","article-title":"PrEP distribution in pharmacies: a systematic review","volume":"12","author":"CE Kennedy","year":"2022","journal-title":"BMJ Open"},{"issue":"6","key":"pone.0311694.ref016","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1071\/SH18084","article-title":"Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care","volume":"15","author":"EL Tung","year":"2018","journal-title":"Sex Health"},{"key":"pone.0311694.ref017","unstructured":"National Alliance of State Pharmacy Association. NASPA. 2022 [cited 2023 Mar 13]. Pharmacist Immunization Authority. Available from: https:\/\/naspa.us\/resource\/pharmacist-authority-to-immunize\/"},{"key":"pone.0311694.ref018","unstructured":"IQVIA Institute for Human Data Science. Trends in Vaccine Administration in the United States [Internet]. Parsippany, NJ; 2023 Jan [cited 2023 Mar 13]. Available from: https:\/\/www.iqvia.com\/insights\/the-iqvia-institute\/reports\/trends-in-vaccine-administration-in-the-united-states"},{"issue":"2","key":"pone.0311694.ref019","doi-asserted-by":"crossref","first-page":"e35590","DOI":"10.2196\/35590","article-title":"Integrating and Disseminating Pre-Exposure Prophylaxis (PrEP) Screening and Dispensing for Black Men Who Have Sex With Men in Atlanta, Georgia: Protocol for Community Pharmacies","volume":"11","author":"ND Crawford","year":"2022","journal-title":"JMIR Res Protoc"},{"issue":"4","key":"pone.0311694.ref020","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.japh.2019.12.003","article-title":"Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men","volume":"60","author":"ND Crawford","year":"2020","journal-title":"J Am Pharm Assoc JAPhA"},{"issue":"5","key":"pone.0311694.ref021","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/0897190020904590","article-title":"Willingness to Discuss and Screen for Pre-Exposure Prophylaxis in Pharmacies Among Men Who Have Sex With Men","volume":"34","author":"ND Crawford","year":"2021","journal-title":"J Pharm Pract"},{"issue":"5","key":"pone.0311694.ref022","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s10461-021-03494-4","article-title":"Pharmacy-Based Interventions to Increase Use of HIV Pre-exposure Prophylaxis in the United States: A Scoping Review","volume":"26","author":"A Zhao","year":"2022","journal-title":"AIDS Behav"},{"issue":"10","key":"pone.0311694.ref023","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz365","article-title":"Acceptability and Feasibility of a Pharmacist-Led Human Immunodeficiency Virus Pre-Exposure Prophylaxis Program in the Midwestern United States","volume":"6","author":"JP Havens","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"pone.0311694.ref024","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.japh.2019.06.021","article-title":"Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health","volume":"60","author":"MI Lopez","year":"2020","journal-title":"J Am Pharm Assoc"},{"issue":"5","key":"pone.0311694.ref025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/apc.2018.0294","article-title":"The Pharmacist\u2019s Expanding Role in HIV Pre-Exposure Prophylaxis","volume":"33","author":"EK Farmer","year":"2019","journal-title":"AIDS Patient Care STDs"},{"key":"pone.0311694.ref026","article-title":"Bringing in new settings and workforce for PrEP delivery: PrEP in pharmacies and other models","author":"R. Patel","year":"2020"},{"key":"pone.0311694.ref027","unstructured":"prepiowa [Internet]. [cited 2023 Mar 8]. Iowa TelePrEP. Available from: https:\/\/www.prepiowa.org\/teleprep"},{"issue":"1","key":"pone.0311694.ref028","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/clinpract13010025","article-title":"Empowering Tennessee Pharmacists to Initiate PrEP Using Collaborative Pharmacy Practice Agreements","volume":"13","author":"A Cernasev","year":"2023","journal-title":"Clin Pract"},{"key":"pone.0311694.ref029","article-title":"Expanding Pharmacist-Prescribed HIV PrEP. ASSOCIATION OF STATE AND TERRITORIAL HEALTH OFFICIALS","author":"R. Scheckman","year":"2023"},{"key":"pone.0311694.ref030","unstructured":"NASTAD. Pharmacist Authority to Initiate PrEP & PEP and Participate in Collaborative Practice Agreements | NASTAD [Internet]. 2023 Aug [cited 2024 Aug 31]. Available from: https:\/\/nastad.org\/resources\/pharmacist-authority-initiate-prep-pep-and-participate-collaborative-practice-agreements"},{"key":"pone.0311694.ref031","unstructured":"Maryland Department of Health. Maryland HIV Update \u2010 2023 [Internet]. Available from: https:\/\/health.maryland.gov\/phpa\/OIDEOR\/CHSE\/SiteAssets\/Pages\/statistics\/Maryland-HIV-Update-2022-%28Data-reported-through-09-30-2023%29.pdf"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0311694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T17:22:00Z","timestamp":1729099320000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0311694"}},"subtitle":[],"editor":[{"given":"Tinashe","family":"Mudzviti","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0311694","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]}}}